Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases

被引:231
作者
Margolin, N [1 ]
Raybuck, SA [1 ]
Wilson, KP [1 ]
Chen, WY [1 ]
Fox, T [1 ]
Gu, Y [1 ]
Livingston, DJ [1 ]
机构
[1] VERTEX PHARMACEUT INC,CAMBRIDGE,MA 02139
关键词
D O I
10.1074/jbc.272.11.7223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-1 beta-converting enzyme (ICE) is a novel cysteine protease responsible for the cleavage of pre-interleukin-1 beta (pre-IL-1 beta) to the mature cytokine and a member of a family of related proteases (the caspases) that includes the Caenorhabditis elegans cell death gene product, CED-3. In addition to their sequence homology, these cysteine proteases display an unusual substrate specificity for peptidyl sequences with a P-1 aspartate residue. We have examined the kinetics of processing pre-IL-1 beta to the mature form by ICE and three of its homologs, TX, CPP-32, and CMH-1. Of the ICE homologs, only TX processes pre-IL-1 beta, albeit with a catalytic efficiency 250-fold less than ICE itself. We also investigated the ability of these four proteases to process poly(ADP-ribose) polymerase, a DNA repair enzyme that is cleaved within minutes of the onset of apoptosis. Every caspase examined cleaves PARP, with catalytic efficiencies ranging from 2.3 x 10(6) M(-1) S-1 for CPP32 to 1.0 x 10(3) M(-1) S-1 for TX. In addition, we report kinetic constants for several reversible inhibitors and irreversible inactivators, which have been used to implicate one or more caspases in the apoptotic proteolysis cascade. Ac-Asp-Glu-Val-Asp aldehyde (DEVD-CHO) is a potent inhibitor of CPP-32 with a K-i value of 0.5 nM, but is also potent as inhibitor of CMH-1 (K-i = 35 nM) and ICE (K-i = 15 nM). The x-ray crystal structure of DEVD-CHO complexed to ICE presented here reveals electrostatic interactions not present in the Ac-YVAD-CHO co-complex structure (Wilson, K. P., Black, J.-A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A, Chambers, S. P., Aldape, R. A., Raybuck, S. A., and Livingston, D. J. (1994) Nature 370, 270-275), accounting for the surprising potency of this inhibitor against ICE.
引用
收藏
页码:7223 / 7228
页数:6
相关论文
共 43 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]  
BLACK RA, 1988, J BIOL CHEM, V263, P9437
[3]  
Brunger AT, 1992, XPLOR VERSION 3 1 MA
[4]   A cleavage-site-directed inhibitor of interleukin 1 beta-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes [J].
Cain, K ;
InayatHussain, SH ;
Couet, C ;
Cohen, GM .
BIOCHEMICAL JOURNAL, 1996, 314 :27-32
[5]   MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME [J].
CERRETTI, DP ;
KOZLOSKY, CJ ;
MOSLEY, B ;
NELSON, N ;
VANNESS, K ;
GREENSTREET, TA ;
MARCH, CJ ;
KRONHEIM, SR ;
DRUCK, T ;
CANNIZZARO, LA ;
HUEBNER, K ;
BLACK, RA .
SCIENCE, 1992, 256 (5053) :97-100
[6]  
CHEN W, 1997, IN PRESS PROTEIN EXP
[7]   P-1 ASPARTATE-BASED PEPTIDE ALPHA-((2,6-DICHLOROBENZOYL)OXY)METHYL KETONES AS POTENT TIME-DEPENDENT INHIBITORS OF INTERLEUKIN-1-BETA-CONVERTING ENZYME [J].
DOLLE, RE ;
HOYER, D ;
PRASAD, CVC ;
SCHMIDT, SJ ;
HELASZEK, CT ;
MILLER, RE ;
ATOR, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :563-564
[8]   INVOLVEMENT OF AN ICE-LIKE PROTEASE IN FAS-MEDIATED APOPTOSIS [J].
ENARI, M ;
HUG, H ;
NAGATA, S .
NATURE, 1995, 375 (6526) :78-81
[9]   A NOVEL HUMAN PROTEASE SIMILAR TO THE INTERLEUKIN-1-BETA CONVERTING-ENZYME INDUCES APOPTOSIS IN TRANSFECTED CELLS [J].
FAUCHEU, C ;
DIU, A ;
CHAN, AWE ;
BLANCHET, AM ;
MIOSSEC, C ;
HERVE, F ;
COLLARDDUTILLEUL, V ;
GU, Y ;
ALDAPE, RA ;
LIPPKE, JA ;
ROCHER, C ;
SU, MSS ;
LIVINGSTON, DJ ;
HERCEND, T ;
LALANNE, JL .
EMBO JOURNAL, 1995, 14 (09) :1914-1922
[10]   Identification of a cysteine protease closely related to interleukin-1 beta-converting enzyme [J].
Faucheu, C ;
Blanchet, AM ;
CollardDutilleul, V ;
Lalanne, JL ;
DiuHercend, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (01) :207-213